165 results
Page 3 of 9
8-K
EX-1.1
yw42gecs4 ajyp00vps
8 Jan 21
Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock
4:02pm
424B5
c1hqu8qn
7 Jan 21
Prospectus supplement for primary offering
5:25pm
424B5
iurgw4 8xv
4 Jan 21
Prospectus supplement for primary offering
4:15pm
8-K
EX-3.1
v3lki7f 3i
22 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-10.1
d6ap 434gsq9os
19 Aug 20
Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
4:01pm
8-K
lrvp181o ctdd2
19 Aug 20
Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
4:01pm
8-K
EX-3.1
oephma7zk iy
19 Aug 20
Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
4:01pm